Our body’s cells are constantly changing. But which of these changes are healthy developments and which lead to serious diseases? This is what LifeTime, a new transnational and interdisciplinary initiative of leading European researchers, aims to…

What is the Speed Lecture Award?

Six young scientists present in three minutes their new projects and ideas in life sciences and healthcare industries in front of the BIONNALE audience of around 800 experts from academia, science and business. The…

At the beginning of 2019, Andrea Runow took over as Head of Finance and Controlling and as acting Chief Financial Officer and Executive Board member of Berlin Institute of Health (BIH). She succeeds Dr. Rolf Zettl, who is leaving BIH after three…

Every tenth child is overweight, every twentieth even obese. Scientists at the Berlin Institute of Health (BIH), together with colleagues at Charité and the Helmholtz Centre for Environmental Research (UFZ) in Leipzig, have now studied a relationship…

Bispecific Antibody for Cancer Treatment Optimized by GlymaxX® Technology

“Multinational research projects on Personalised Medicine for Neurodegenerative Diseases”

More than €10 million in funding awarded to Charité

The research partnership between the University of Oxford and the four Berlin partners – Freie Universität Berlin, Humboldt-Universität zu Berlin, Technische Universität Berlin, and Charité – Universitätsmedizin Berlin – is picking up speed: all five…

Findings include stable disease and prolonged time on treatment vs. prior therapy in heavily pretreated metastatic pancreatic and colorectal cancer patients

The fatty acid propionate helps defend against the effects of high blood pressure, including atherosclerosis and heart tissue remodeling, a study on mice has found. Gut bacteria produce the substance – which calms the immune cells that drive up blood…